Effect of risperidone on prolactinoma growth in a psychotic woman

被引:20
作者
Pal, JK
Sarino, WA
机构
[1] Mt Sinai Hosp, Dept Psychiat, Chicago, IL USA
[2] Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA
来源
PSYCHOSOMATIC MEDICINE | 2000年 / 62卷 / 05期
关键词
psychosis; prolactinoma; atypical antipsychotic;
D O I
10.1097/00006842-200009000-00018
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The case of a psychotic woman is described in which risperidone use was found to correspond with an increase in the size of a prolactinoma and prevented the return of serum prolactin level to baseline. Methods: Although the patient had been treated with a high dose of bromocriptine, her prolactin level remained elevated, causing persistent galactorrhea. The patient later was treated with olanzapine and carbamazepine successfully. Results: This case report highlights the role of risperidone on prolactin and discusses alternative methods of treating psychosis when the etiology is unclear, especially in younger patients. Conclusions: The authors recommend that additional studies regarding the relationship between the growth of prolactinoma and atypical antipsychotics would be worthwhile.
引用
收藏
页码:736 / 738
页数:3
相关论文
共 25 条
[1]   PROGRESSIVE TRABECULAR OSTEOPENIA IN WOMEN WITH HYPERPROLACTINEMIC AMENORRHEA [J].
BILLER, BMK ;
BAUM, HBA ;
ROSENTHAL, DI ;
SAXE, VC ;
CHARPIE, PM ;
KLIBANSKI, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (03) :692-697
[2]   EFFECTS OF CARBAMAZEPINE ON PROLACTIN SECRETION IN NORMAL SUBJECTS AND IN EPILEPTIC SUBJECTS [J].
BONUCCELLI, U ;
MURIALDO, G ;
MARTINO, E ;
LECCHINI, S ;
BONURA, ML ;
BAMBINI, G ;
MURRI, L .
CLINICAL NEUROPHARMACOLOGY, 1985, 8 (02) :165-174
[3]   The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations [J].
Crawford, AMK ;
Beasley, CM ;
Tollefson, GD .
SCHIZOPHRENIA RESEARCH, 1997, 26 (01) :41-54
[4]   THE EFFECT OF NEUROLEPTICS ON PROLACTINOMA GROWTH IN A JORDANIAN SCHIZOPHRENIC GIRL [J].
DARADKEH, TK ;
AJLOUNI, KM .
ACTA PSYCHIATRICA SCANDINAVICA, 1988, 77 (02) :228-229
[5]  
DELAFUENTE JR, 1981, AM J PSYCHIAT, V138, P1154
[6]  
DICKSON RA, 1995, AM J PSYCHIAT, V152, P1102
[7]  
GRUEN PH, 1978, ARCH GEN PSYCHIAT, V35, P108
[8]  
HAMMER MB, 1996, PSYCHOPHARMACOL B, V32, P107
[9]   Risperidone treatment of children and adolescents with developmental disorders [J].
Hardan, A ;
Johnson, K ;
Johnson, C ;
Hrecznyj, B .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1996, 35 (11) :1551-1556
[10]  
KAYATH MJ, 1993, BRAZ J MED BIOL RES, V26, P933